ft 22 apr 91 queen award export technolog 1991 treatment get skin cure cancer ici pharmaceut ici pharmaceut base alderley park cheshir fourth award technolog achiev year award zoladex innov prostat cancer treatment step forward pharmaceut chemistri also drug deliveri technolog zoladex cannot taken oral break quickli gastro intestin tract administ daili inject ici research consid method suitabl long term use instead develop sustain releas formul activ drug dispers small cylind biodegrad polym size colour rice grain depot inject skin gradual releas drug period one month patient typic elderli man visit doctor everi four week new depot insert zoladex synthet chemic analogu natur hormon lhrh releas hypothalamu act pituitari gland much potent lhrh block action natur hormon interfer seri hormon driven reaction bodi outcom zoladex treatment stop test produc testosteron male sex hormon tumour prostat gland depend testosteron grow product stop cancer effect cure tradit achiev surgic remov test zoladex bring effect chemic therefor avoid psycholog trauma medic risk surgic castrat ici chemist first synthesis activ ingredi zoladex 1976 initi biolog test shown promis result enter develop stage 1978 zoladex launch commerci 1987 11 year interv discoveri market averag intern pharmaceut industri show long timescal r amp strategist oper zoladex sale 20 countri includ major pharmaceut market although use far prostat cancer zoladex recent approv treat breast cancer sever european countri ici develop variou hormon relat diseas ici declin disclos current project sale figur zoladex analyst believ could eventu reach pound 100m year prostat cancer pound 100m year breast cancer diseas last novemb ici open pound 13 5m plant macclesfield cheshir make zoladex demand great pound 8 5m extens sanction main plant complet whole factori capac make 2m monthli dose zoladex per year develop zoladex grew ici long stand expertis hormon base cancer treatment anti oestrogen breast cancer drug nolvadex launch 1973 winner queen award technolog achiev 1978 world best sell cancer medicin mr david friend chief execut ici pharmaceut say cancer therapi account larg proport compani pound 200m year expenditur drug research develop pharmaceut busi current star perform ici group 1990 account show sale pound 1 4bn trade profit pound 489m ici pharmaceut account 11 per cent group turnov contribut 47 5 per cent profit compani expect strong growth ici pharmaceut year busi remain mire depress affect gener chemic industri